vs
安捷伦科技（A）与Addus HomeCare Corp（ADUS）财务数据对比。点击上方公司名可切换其他公司
安捷伦科技的季度营收约是Addus HomeCare Corp的4.8倍（$1.8B vs $373.1M）。安捷伦科技净利率更高（17.0% vs 8.0%，领先9.0%）。Addus HomeCare Corp同比增速更快（25.6% vs 7.0%）。安捷伦科技自由现金流更多（$175.0M vs $16.1M）。过去两年Addus HomeCare Corp的营收复合增速更高（15.3% vs 6.9%）
安捷伦科技是全球知名的生命科学、诊断与应用化学领域解决方案提供商，旗下生命科学与应用市场业务板块提供液相色谱系统及组件、液相色谱质谱联用系统、气相色谱设备、电感耦合等离子体质谱仪、原子吸收仪等多种分析检测仪器，服务全球各领域客户。
Addus HomeCare Corp是一家总部位于美国的家庭护理服务提供商，主要为老年人、残障人士及慢性病患者提供个人护理、居家健康支持、临终关怀等服务，业务覆盖美国多个州，合作方包括政府支付机构、私营保险公司及个人客户。
A vs ADUS — 直观对比
营收规模更大
A
是对方的4.8倍
$373.1M
营收增速更快
ADUS
高出18.6%
7.0%
净利率更高
A
高出9.0%
8.0%
自由现金流更多
A
多$158.9M
$16.1M
两年增速更快
ADUS
近两年复合增速
6.9%
损益表 — Q1 2026 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $1.8B | $373.1M |
| 净利润 | $305.0M | $29.8M |
| 毛利率 | 52.6% | 33.1% |
| 营业利润率 | 19.6% | 11.3% |
| 净利率 | 17.0% | 8.0% |
| 营收同比 | 7.0% | 25.6% |
| 净利润同比 | -4.1% | 52.5% |
| 每股收益（稀释后） | $1.07 | $1.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AADUS
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.9B | $373.1M | ||
| Q3 25 | $1.7B | $362.3M | ||
| Q2 25 | $1.7B | $349.4M | ||
| Q1 25 | $1.7B | $337.7M | ||
| Q4 24 | $1.7B | $297.1M | ||
| Q3 24 | $1.6B | $289.8M | ||
| Q2 24 | $1.6B | $286.9M |
净利润AADUS
| Q1 26 | $305.0M | — | ||
| Q4 25 | $434.0M | $29.8M | ||
| Q3 25 | $336.0M | $22.8M | ||
| Q2 25 | $215.0M | $22.1M | ||
| Q1 25 | $318.0M | $21.2M | ||
| Q4 24 | $351.0M | $19.5M | ||
| Q3 24 | $282.0M | $20.2M | ||
| Q2 24 | $308.0M | $18.1M |
毛利率AADUS
| Q1 26 | 52.6% | — | ||
| Q4 25 | 53.2% | 33.1% | ||
| Q3 25 | 51.1% | 32.2% | ||
| Q2 25 | 51.9% | 32.6% | ||
| Q1 25 | 53.5% | 31.9% | ||
| Q4 24 | 53.9% | 34.2% | ||
| Q3 24 | 54.2% | 31.8% | ||
| Q2 24 | 54.4% | 32.5% |
营业利润率AADUS
| Q1 26 | 19.6% | — | ||
| Q4 25 | 23.8% | 11.3% | ||
| Q3 25 | 20.7% | 9.1% | ||
| Q2 25 | 18.0% | 9.4% | ||
| Q1 25 | 22.4% | 9.0% | ||
| Q4 24 | 24.0% | 9.1% | ||
| Q3 24 | 21.1% | 9.0% | ||
| Q2 24 | 23.1% | 9.1% |
净利率AADUS
| Q1 26 | 17.0% | — | ||
| Q4 25 | 23.3% | 8.0% | ||
| Q3 25 | 19.3% | 6.3% | ||
| Q2 25 | 12.9% | 6.3% | ||
| Q1 25 | 18.9% | 6.3% | ||
| Q4 24 | 20.6% | 6.6% | ||
| Q3 24 | 17.9% | 7.0% | ||
| Q2 24 | 19.6% | 6.3% |
每股收益（稀释后）AADUS
| Q1 26 | $1.07 | — | ||
| Q4 25 | $1.53 | $1.62 | ||
| Q3 25 | $1.18 | $1.24 | ||
| Q2 25 | $0.75 | $1.20 | ||
| Q1 25 | $1.11 | $1.16 | ||
| Q4 24 | $1.23 | $1.06 | ||
| Q3 24 | $0.97 | $1.10 | ||
| Q2 24 | $1.05 | $1.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.8B | — |
| 总债务越低越好 | $3.0B | $121.0M |
| 股东权益账面价值 | $6.9B | $1.1B |
| 总资产 | $12.8B | $1.4B |
| 负债/权益比越低杠杆越低 | 0.44× | 0.11× |
8季度趋势，按日历期对齐
现金及短期投资AADUS
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.8B | — | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.5B | $97.0M | ||
| Q4 24 | $1.3B | $98.9M | ||
| Q3 24 | $1.8B | $222.9M | ||
| Q2 24 | $1.7B | $173.3M |
总债务AADUS
| Q1 26 | $3.0B | — | ||
| Q4 25 | $3.0B | $121.0M | ||
| Q3 25 | $3.4B | $150.6M | ||
| Q2 25 | $3.3B | $169.1M | ||
| Q1 25 | $3.3B | — | ||
| Q4 24 | $3.3B | $218.4M | ||
| Q3 24 | $2.1B | — | ||
| Q2 24 | $2.1B | — |
股东权益AADUS
| Q1 26 | $6.9B | — | ||
| Q4 25 | $6.7B | $1.1B | ||
| Q3 25 | $6.4B | $1.0B | ||
| Q2 25 | $6.1B | $1.0B | ||
| Q1 25 | $6.0B | $995.4M | ||
| Q4 24 | $5.9B | $970.5M | ||
| Q3 24 | $5.9B | $947.6M | ||
| Q2 24 | $6.2B | $921.7M |
总资产AADUS
| Q1 26 | $12.8B | — | ||
| Q4 25 | $12.7B | $1.4B | ||
| Q3 25 | $12.2B | $1.4B | ||
| Q2 25 | $12.2B | $1.4B | ||
| Q1 25 | $11.9B | $1.4B | ||
| Q4 24 | $11.8B | $1.4B | ||
| Q3 24 | $11.0B | $1.2B | ||
| Q2 24 | $10.9B | $1.1B |
负债/权益比AADUS
| Q1 26 | 0.44× | — | ||
| Q4 25 | 0.45× | 0.11× | ||
| Q3 25 | 0.53× | 0.14× | ||
| Q2 25 | 0.55× | 0.17× | ||
| Q1 25 | 0.56× | — | ||
| Q4 24 | 0.57× | 0.23× | ||
| Q3 24 | 0.36× | — | ||
| Q2 24 | 0.34× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $268.0M | $18.8M |
| 自由现金流经营现金流 - 资本支出 | $175.0M | $16.1M |
| 自由现金流率自由现金流/营收 | 9.7% | 4.3% |
| 资本支出强度资本支出/营收 | 5.2% | 0.7% |
| 现金转化率经营现金流/净利润 | 0.88× | 0.63× |
| 过去12个月自由现金流最近4个季度 | $993.0M | $103.8M |
8季度趋势，按日历期对齐
经营现金流AADUS
| Q1 26 | $268.0M | — | ||
| Q4 25 | $545.0M | $18.8M | ||
| Q3 25 | $362.0M | $51.3M | ||
| Q2 25 | $221.0M | $22.5M | ||
| Q1 25 | $431.0M | $18.9M | ||
| Q4 24 | $481.0M | $10.4M | ||
| Q3 24 | $452.0M | $48.5M | ||
| Q2 24 | $333.0M | $18.8M |
自由现金流AADUS
| Q1 26 | $175.0M | — | ||
| Q4 25 | $452.0M | $16.1M | ||
| Q3 25 | $259.0M | $49.3M | ||
| Q2 25 | $107.0M | $21.3M | ||
| Q1 25 | $334.0M | $17.1M | ||
| Q4 24 | $388.0M | $8.7M | ||
| Q3 24 | $360.0M | $46.6M | ||
| Q2 24 | $230.0M | $17.7M |
自由现金流率AADUS
| Q1 26 | 9.7% | — | ||
| Q4 25 | 24.3% | 4.3% | ||
| Q3 25 | 14.9% | 13.6% | ||
| Q2 25 | 6.4% | 6.1% | ||
| Q1 25 | 19.9% | 5.1% | ||
| Q4 24 | 22.8% | 2.9% | ||
| Q3 24 | 22.8% | 16.1% | ||
| Q2 24 | 14.6% | 6.2% |
资本支出强度AADUS
| Q1 26 | 5.2% | — | ||
| Q4 25 | 5.0% | 0.7% | ||
| Q3 25 | 5.9% | 0.5% | ||
| Q2 25 | 6.8% | 0.4% | ||
| Q1 25 | 5.8% | 0.6% | ||
| Q4 24 | 5.5% | 0.6% | ||
| Q3 24 | 5.8% | 0.7% | ||
| Q2 24 | 6.5% | 0.4% |
现金转化率AADUS
| Q1 26 | 0.88× | — | ||
| Q4 25 | 1.26× | 0.63× | ||
| Q3 25 | 1.08× | 2.24× | ||
| Q2 25 | 1.03× | 1.02× | ||
| Q1 25 | 1.36× | 0.89× | ||
| Q4 24 | 1.37× | 0.53× | ||
| Q3 24 | 1.60× | 2.41× | ||
| Q2 24 | 1.08× | 1.04× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
A
| Service Other | $525.0M | 29% |
| Chemicaland Energy Market | $422.0M | 23% |
| Agilent Cross Lab | $273.0M | 15% |
| Environmentaland Forensics Market | $177.0M | 10% |
| Food Market | $166.0M | 9% |
| Academiaand Government Market | $130.0M | 7% |
| Applied Markets | $98.0M | 5% |
ADUS
| Personal Care | $286.0M | 77% |
| Hospice | $70.0M | 19% |
| Home Health | $17.1M | 5% |
